Vigil Neuroscience Revenue vs. Debt To Equity
| VIGL Stock | USD 2.30 0.10 4.55% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
For Vigil Neuroscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vigil Neuroscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vigil Neuroscience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vigil Neuroscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vigil Neuroscience over time as well as its relative position and ranking within its peers.
Vigil |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.07) | Return On Assets (0.40) | Return On Equity (0.70) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vigil Neuroscience Debt To Equity vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Vigil Neuroscience's current stock value. Our valuation model uses many indicators to compare Vigil Neuroscience value to that of its competitors to determine the firm's financial worth. Vigil Neuroscience is currently under evaluation in revenue category among its peers. It is rated below average in debt to equity category among its peers . At this time, Vigil Neuroscience's Total Revenue is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Vigil Neuroscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Vigil Revenue vs. Competition
Vigil Neuroscience is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 15.06 Million. Vigil Neuroscience adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.
Vigil Debt To Equity vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Vigil Neuroscience |
| = | null |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Vigil Neuroscience |
| = | 0 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Vigil Debt To Equity Comparison
Vigil Neuroscience is currently under evaluation in debt to equity category among its peers.
Vigil Neuroscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Vigil Neuroscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vigil Neuroscience will eventually generate negative long term returns. The profitability progress is the general direction of Vigil Neuroscience's change in net profit over the period of time. It can combine multiple indicators of Vigil Neuroscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5 K | -4.8 K | |
| Operating Income | -88.9 M | -84.4 M | |
| Income Before Tax | -82.6 M | -86.8 M | |
| Total Other Income Expense Net | 6.2 M | 6.5 M | |
| Net Loss | -61.5 M | -64.5 M | |
| Net Loss | -82.6 M | -86.8 M | |
| Income Tax Expense | -521.1 K | -495 K | |
| Net Interest Income | 5 M | 5.2 M | |
| Interest Income | 5 M | 5.2 M | |
| Net Loss | -78.9 M | -82.9 M | |
| Non Operating Income Net Other | 521.1 K | 463.2 K | |
| Change To Netincome | 4.9 M | 4.7 M | |
| Net Loss | (2.13) | (2.24) | |
| Income Quality | 0.85 | 0.58 | |
| Net Income Per E B T | 1.14 | 1.10 |
Vigil Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Vigil Neuroscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vigil Neuroscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vigil Neuroscience's important profitability drivers and their relationship over time.
Use Vigil Neuroscience in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vigil Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will appreciate offsetting losses from the drop in the long position's value.Vigil Neuroscience Pair Trading
Vigil Neuroscience Pair Trading Analysis
The ability to find closely correlated positions to Vigil Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vigil Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vigil Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vigil Neuroscience to buy it.
The correlation of Vigil Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vigil Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vigil Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vigil Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Vigil Neuroscience position
In addition to having Vigil Neuroscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
To fully project Vigil Neuroscience's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vigil Neuroscience at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vigil Neuroscience's income statement, its balance sheet, and the statement of cash flows.